BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19090501)

  • 21. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.
    Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study.
    Amor F; Alcázar JL; Vaccaro H; León M; Iturra A
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):450-5. PubMed ID: 21465605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin.
    Valentin L
    Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):63-72. PubMed ID: 9076424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vessel morphology depicted by three-dimensional power Doppler ultrasound as second-stage test in adnexal tumors that are difficult to classify: prospective diagnostic accuracy study.
    Sladkevicius P; Jokubkiene L; Timmerman D; Fischerova D; Van Holsbeke C; Franchi D; Savelli L; Epstein E; Fruscio R; Kaijser J; Czekierdowski A; Guerriero S; Pascual MA; Testa AC; Ameye L; Valentin L
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):324-334. PubMed ID: 32853459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically oriented three-step strategy for assessment of adnexal pathology.
    Ameye L; Timmerman D; Valentin L; Paladini D; Zhang J; Van Holsbeke C; Lissoni AA; Savelli L; Veldman J; Testa AC; Amant F; Van Huffel S; Bourne T
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):582-91. PubMed ID: 22511559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sonographic diagnosis of presumed benign ovarian tumors].
    Marret H; Cayrol M
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):730-43. PubMed ID: 24200073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
    Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new scoring system to differentiate benign from malignant adnexal masses.
    Alcázar JL; Mercé LT; Laparte C; Jurado M; López-García G
    Am J Obstet Gynecol; 2003 Mar; 188(3):685-92. PubMed ID: 12634641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
    Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
    Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation of ADNEX MR SCORING system: a single-centre retrospective study.
    Sasaguri K; Yamaguchi K; Nakazono T; Mizuguchi M; Aishima S; Yokoyama M; Irie H
    Clin Radiol; 2019 Feb; 74(2):131-139. PubMed ID: 30514585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing clinical performance of gynecology residents: sonographic evaluation of adnexal masses based on morphological scoring systems.
    Lee TS; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Ultrasound Obstet Gynecol; 2005 Dec; 26(7):776-9. PubMed ID: 16308902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound experience substantially impacts on diagnostic performance and confidence when adnexal masses are classified using pattern recognition.
    Van Holsbeke C; Daemen A; Yazbek J; Holland TK; Bourne T; Mesens T; Lannoo L; Boes AS; Joos A; Van De Vijver A; Roggen N; de Moor B; de Jonge E; Testa AC; Valentin L; Jurkovic D; Timmerman D
    Gynecol Obstet Invest; 2010; 69(3):160-8. PubMed ID: 20016188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triage for surgical management of ovarian tumors in asymptomatic women: assessment of an ultrasound-based scoring system.
    Alcázar JL; Royo P; Jurado M; Mínguez JA; García-Manero M; Laparte C; Galván R; López-García G
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):220-5. PubMed ID: 18618475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.